Saturday 7 November 2026
Export AIRS’s income statement to Excel — free account
AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024.
- Revenue
- −8.71%
- EPS
- +33.3%
- Free cash flow
- −813.8%
- Total debt
- −90.4%
Quarter to September 2026, against a year earlier
0.55
0.89
−61.81%
Follow AIRS
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | 41 | 63 | 133 | 169 | 196 | 180 | 152 | 148 | +24.3% | 151 | 155 | 161 | +1.9% | |
| Gross margin, % | — | — | — | 62.44 | 62.61 | 66.59 | 62.81 | 62.34 | 60.55 | 59.37 | 0.00 | (3.1) pt | ||||||
| EBT | — | — | — | (2) | 8 | 11 | (11) | 3 | (8) | (18) | (18) | +41.3% | ||||||
| EBT margin, % | — | — | — | (5.36) | 12.07 | 8.16 | (6.69) | 1.65 | (4.34) | (11.62) | 0.00 | (6.3) pt | ||||||
| Net income | — | 0 | — | (2) | 8 | 11 | (15) | (4) | (8) | (12) | (12) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | 0.74 | 1.13 | 2.40 | 3.03 | 3.45 | 3.13 | 2.51 | 2.04 | +22.6% | |||||
| Earnings | — | — | — | (0.04) | 0.14 | (0.01) | (0.26) | (0.08) | (0.14) | (0.19) | (0.13) | +29.7% | ||||||
| Cash flow | — | — | — | 0.09 | 0.25 | 0.48 | 0.44 | 0.42 | 0.20 | 0.05 | (0.03) | (8.8%) | ||||||
| Capex | — | — | — | (0.08) | (0.07) | (0.13) | (0.23) | (0.17) | (0.24) | (0.04) | (0.01) | (10.9%) | ||||||
| Free cash flow | — | — | — | 0.01 | 0.18 | 0.35 | 0.21 | 0.25 | (0.05) | 0.01 | (0.03) | +4.0% | ||||||
| Book value | — | — | — | 2.16 | 2.22 | 1.50 | 1.27 | 1.48 | 1.36 | 1.45 | 1.46 | (6.4%) | ||||||
| Shares, m | — | — | — | 56 | 56 | 56 | 56 | 57 | 58 | 60 | 68 | +1.4% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | 33.81 | 33.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.7 | |||||
| P/S | — | — | — | 7.45 | 7.45 | 7.17 | 1.22 | 2.08 | 1.66 | 0.79 | 0.27 | 4.0 | ||||||
| P/B | — | — | — | 0.00 | 0.00 | 11.45 | 2.92 | 4.86 | 3.83 | 1.36 | 0.38 | 3.5 | ||||||
| EV/Sales | — | — | — | 8.31 | 8.31 | 7.60 | 1.66 | 2.40 | 2.03 | 1.10 | 0.43 | 4.5 | ||||||
| EV/FCF | — | — | — | 26.02 | 26.02 | 51.94 | 24.34 | 33.45 | (137.70) | 241.75 | (24.95) | 38.0 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | 5 | 14 | 27 | 24 | 24 | 11 | 3 | (2) | (7.5%) | |||||
| Capex | — | — | — | (4) | (4) | (7) | (13) | (10) | (14) | (2) | (1) | (9.7%) | ||||||
| Free cash flow | — | — | — | 0 | 10 | 20 | 12 | 14 | (3) | 1 | (3) | +5.6% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | (2) | 2 | 13 | (6) | (4) | (12) | (12) | (4) | +38.5% | |||||
| Net debt | — | — | — | 28 | 22 | 57 | 74 | 61 | 66 | 48 | (10) | +9.5% | ||||||
| Shareholders’ equity | — | — | — | 120 | 124 | 84 | 71 | 84 | 78 | 88 | 106 | (5.1%) | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | (2.58) | 4.32 | (0.21) | (7.32) | (2.09) | (3.85) | (5.83) | 0.00 | (3.2) pt | |||||
| ROIC | — | — | — | 0.28 | 4.30 | 7.00 | (1.96) | 4.18 | (0.68) | (5.34) | 0.00 | (5.6) pt | ||||||
| ROE | — | — | — | (1.81) | 6.21 | (0.38) | (19.03) | (5.48) | (9.89) | (14.07) | 0.00 | (12.3) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | 260 | 268 | 302 | 381 | 422 | 363 | — | +6.9% | |||||
| Revenue/emp, $m | — | — | — | 0.00 | 0.24 | 0.50 | 0.56 | 0.51 | 0.43 | 0.42 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026
AirSculpt Technologies, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| AUNA Auna S.A. | $339.7M | 66.7× | 6.1× | +20.51% (above 0%: growing) | −61.29% (below 0%: shrinking) | +121.08% (above 0%: growing) | 35.72% | 13.09% | Compare |
| CYH Community Health Systems, Inc. | $321.5M | 4.2× | — (loss-making) | −10.69% (below 0%: shrinking) | n/m | +857.14% (above 0%: growing) | 85.24% | 5.30% | Compare |
| JYNT The Joint Corp. | $104.2M | 25.5× | 20.1× | +14.41% (above 0%: growing) | +400.00% (above 0%: growing) | +432.31% (above 0%: growing) | 83.68% | (2.43%) | Compare |
| AIRS AirSculpt Technologies, Inc. | $103.8M | — (loss-making) | — (loss-making) | −8.71% (below 0%: shrinking) | n/m | −813.83% (below 0%: shrinking) | 0.00% | 0.00% | |
| PARK Park Dental Partners, Inc. | $95.8M | — (loss-making) | — | +12.15% (above 0%: growing) | −65.84% (below 0%: shrinking) | −34.78% (below 0%: shrinking) | 14.37% | 1.90% | Compare |
| BMGL Basel Medical Group Ltd | $70.5M | — | — | — | — | — | — | — | Compare |
| CCEL Cryo-Cell International Inc. | $39.9M | — (loss-making) | 65.1× | −0.02% (below 0%: shrinking) | +77.78% (above 0%: growing) | −58.37% (below 0%: shrinking) | 79.38% | 28.04% | Compare |
| BTMD biote Corp. | $37.4M | 6.6× | — (loss-making) | −9.48% (below 0%: shrinking) | n/m | −174.16% (below 0%: shrinking) | 65.38% | (7.93%) | Compare |
| PIII P3 Health Partners Inc. | $28.1M | — (loss-making) | — | +8.60% (above 0%: growing) | n/m | −272.24% (below 0%: shrinking) | 22.26% | 10.67% | Compare |
| Median of peers | $83.1M | 16.1× | 20.1× | +8.60% | +8.25% | −34.78% | 65.38% | 5.30% |